Paediatric Palliative Care Pain Management in the Community

Status Recruiting

Clinical Trial Summary

To describe the the barriers and facilitators experienced by carers and healthcare professionals when managing medicines for pain relief for infants, children, and young people approaching the end of life in out of hospital settings.

Clinical Trial Description

This study aims to hear about the experiences of patients, carers and healthcare professionals when managing pain relief medicines for infants, children and young people (ICYP) at the end of their lives, when they are not in hospital.

The study plans to develop a guide to help educate and empower both carers and healthcare professionals in the best ways to manage pain in this group of patients. This guide will contain basic, easily understood information depending upon both the patient's and carers' needs. Family carers are important in looking after their ICYP with life-threatening illnesses, so they can be cared for at home if they wish. Even with varying levels of support from hospice, hospital or family doctors, such responsibility can be rewarding and scary.

Community based healthcare professionals often have little experience to be able to support good end of life pain care in these patients when at home and there may be problems which prevent them from giving effective treatment. If pain and other symptoms are not well controlled by medicines families often move from their chosen place of care. Carers need to be able to check symptoms to decide which medicines to give and how well they are working, without having any special training; some may have unhelpful views about medicines such as morphine.

Not much research has looked at the problems that carers and healthcare professionals come across when trying to manage a child's pain when they are not in hospital.

Research has already shown that being able to provide the right medicine at the right time means children can be looked after where they want, without unnecessary hospital admissions. It is hoped that the guide will make carers feel more confident in managing pain relief safely, so lessening any worries. Future research is planned to show the value of the guide in a larger study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04519632
Study type	Observational
Source	University of Southampton
Contact	Simone Holley, PhD
Phone	00442380595083
Email	s.l.holley@soton.ac.uk
Status	Recruiting
Phase
Start date	July 15, 2019
Completion date	January 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05818644` - Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
Not yet recruiting	`NCT06018324` - CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
Not yet recruiting	`NCT04523623` - Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries	N/A
Completed	`NCT02930850` - Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation	N/A
Completed	`NCT03385681` - Pediatric Pain Management - an Intervention Study	N/A
Completed	`NCT00229671` - Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics	N/A
Completed	`NCT04465370` - Pediatric Cardiac Output Monitoring Observational Study
Recruiting	`NCT04100070` - Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study	N/A
Not yet recruiting	`NCT06035757` - The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery	Phase 4
Completed	`NCT03369847` - Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge	Phase 4
Completed	`NCT05474170` - Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest	N/A
Recruiting	`NCT05230004` - Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth	N/A
Completed	`NCT05731401` - Expressed Beliefs About the Cause of Pain in a Paediatric Population
Completed	`NCT05818215` - Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Completed	`NCT06376188` - Improving Breaking Bad News in Pediatrics by Simulated Communication	N/A
Completed	`NCT04589910` - Measuring Thickness of the Normal Diaphragm in Children Via Ultrasound.	N/A
Recruiting	`NCT04252508` - Impact of a Double-reading Animated Film (Child, Parents) in Preoperative on the Anxiety of Children Upon Arrival at the Operating Room	N/A
Completed	`NCT04655378` - Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura
Completed	`NCT04610918` - Comparing Body Composition Assessment Methods
Completed	`NCT03964259` - Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Paediatric Palliative Care Pain Management in the Community — PARAMOUNT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms